Clinical Trials · NCT01279915
A Safety and Pharmacokinetics Study of ASP0456 in Healthy Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Astellas Pharma Inc
- Enrollment
- 32
- Start date
- Oct 2010
- Locations
- 1 site, Japan
- Primary endpoint
- Pharmacokinetics of ASP0456 assessed by its plasma concentration change